DK354076A - Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning - Google Patents

Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning

Info

Publication number
DK354076A
DK354076A DK354076A DK354076A DK354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A DK 354076 A DK354076 A DK 354076A
Authority
DK
Denmark
Prior art keywords
oxazepine
dibenz
solubilized
piperazinyl
chloro
Prior art date
Application number
DK354076A
Other languages
English (en)
Other versions
DK147727B (da
DK147727C (da
Inventor
B E Haeger
J E Krueger
J A Lowery
L Ritter
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK354076A publication Critical patent/DK354076A/da
Publication of DK147727B publication Critical patent/DK147727B/da
Application granted granted Critical
Publication of DK147727C publication Critical patent/DK147727C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK354076A 1975-08-06 1976-08-05 Fremgangsmaade til fremstilling af en solubiliseret og stabiliseret oploesning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepin eller et farmaceutisk acceptabelt salt deraf DK147727C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60233175A 1975-08-06 1975-08-06
US60233175 1975-08-06

Publications (3)

Publication Number Publication Date
DK354076A true DK354076A (da) 1977-02-07
DK147727B DK147727B (da) 1984-11-26
DK147727C DK147727C (da) 1985-06-17

Family

ID=24410918

Family Applications (1)

Application Number Title Priority Date Filing Date
DK354076A DK147727C (da) 1975-08-06 1976-08-05 Fremgangsmaade til fremstilling af en solubiliseret og stabiliseret oploesning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepin eller et farmaceutisk acceptabelt salt deraf

Country Status (19)

Country Link
JP (1) JPS5221313A (da)
AR (1) AR210501A1 (da)
AT (1) AT345464B (da)
AU (1) AU500641B2 (da)
BE (1) BE844903A (da)
CA (1) CA1069823A (da)
DE (1) DE2633943A1 (da)
DK (1) DK147727C (da)
EG (1) EG12425A (da)
ES (1) ES450520A1 (da)
FI (1) FI762171A (da)
FR (1) FR2320102A1 (da)
GB (1) GB1546933A (da)
IL (1) IL49996A (da)
NL (1) NL7608575A (da)
NO (1) NO146457C (da)
PT (1) PT65400B (da)
SE (1) SE431716B (da)
ZA (1) ZA764052B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739254B1 (fr) * 1995-09-29 1997-12-19 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
FR2739255B1 (fr) * 1995-09-29 1998-09-04 Rhone Merieux Composition antiparasitaire pour le traitement et la protection des animaux de compagnie
IE80657B1 (en) * 1996-03-29 1998-11-04 Merial Sas Insecticidal combination to control mammal fleas in particular fleas on cats and dogs
AU2010224685A1 (en) 2009-03-18 2011-11-03 Fidopharm, Inc. Parasiticidal formulation

Also Published As

Publication number Publication date
EG12425A (en) 1979-06-30
DE2633943A1 (de) 1977-02-17
SE431716B (sv) 1984-02-27
PT65400A (en) 1976-08-01
PT65400B (en) 1978-01-27
DK147727B (da) 1984-11-26
AU1577576A (en) 1978-01-12
SE7608810L (sv) 1977-02-07
NO146457C (no) 1982-10-06
JPS5221313A (en) 1977-02-17
ZA764052B (en) 1977-06-29
FR2320102A1 (fr) 1977-03-04
ATA581376A (de) 1978-01-15
DK147727C (da) 1985-06-17
IL49996A (en) 1981-01-30
IL49996A0 (en) 1976-09-30
ES450520A1 (es) 1978-05-01
NL7608575A (nl) 1977-02-08
NO146457B (no) 1982-06-28
NO762713L (da) 1977-02-08
FI762171A (da) 1977-02-07
CA1069823A (en) 1980-01-15
AR210501A1 (es) 1977-08-15
AU500641B2 (en) 1979-05-31
BE844903A (fr) 1977-02-07
GB1546933A (en) 1979-05-31
AT345464B (de) 1978-09-25

Similar Documents

Publication Publication Date Title
DK327777A (da) Medicinsk hjelpemiddel ved indforing af et instrument gennem munden
ZA765515B (en) Freeze-thaw stable self-inverting water-in-oil emulsion
JPS5395943A (en) 3-di-o-methylfortemycins
NL161963C (nl) Statische neutralisator.
BR7905331A (pt) Circuito de controle de solenoide
SE7707790L (sv) Teckpappersmaterial ("lineboard composition"), jemte forfarande for dess framstellning
IT8025711A0 (it) Circuito oscillatore controllato in fase automatico.
DK154299C (da) Analogifremgangsmaade til fremstilling af dibenzoimidazo-azepiner, -oxazepiner og -thiazepiner
IT8026254A0 (it) Circuito di controllo d'orologio.
BR8004993A (pt) Circuito de controle
JPS5294873A (en) Thin membrane evaporator particularly for highhboiling point substances
NZ183634A (en) N-tetrazol-s'-yl-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-ylcarboxamides
DK319776A (da) Farmaceutisk middel indeholdende den frie base eller pamoatsaltet af substituerede dibenz (b,f)-(1,4) oxazepiner og fremgangsmade til fremstilling deraf
NO157461C (no) Hydrogenutviklende elektrode.
DK354076A (da) Solubiliseret og stabiliseret oplosning indeholdende 2-chlor-11-(4-methyl-1-piperazinyl)-dibenz (b,f) (1,4) oxazepin eller et syreadditionssalt deraf samt fremgangsmade til fremstilling af en sadan oplosning
DK159790C (da) Elektrode til elektrolyseceller, samt anvendelse af en saadan.
JPS5697529A (en) Automatic manufacture of solution from noxious substance on environment
BE857629A (fr) Compositions stabilisees de 1,1,1-trichloroethane
JPS52134086A (en) Stabilized liquid enzyme reagent composition
BR8000482A (pt) Circuito detector de corrente
JPS52117434A (en) Stabilized bloodiologic reagent solution
BE851591A (fr) Composition de poly (phosphazene) stabilisee
NO771437L (no) Biologisk aktivt stoff.
NL172050C (nl) Ontstekersas bevattende tetrazeen.
JPS5328143A (en) On chemical substance*n*nndichloroopp*n*nn dichloroaminomethyl*benzenesulfonamide

Legal Events

Date Code Title Description
PUP Patent expired